JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4676
Rigel Pharmaceuticals
RIGL
$893M
| $105K | ﹤0.01% |
4,096
-193
| -4% | -$4.41K |
2016 Q2
11 quarters
|
|
|
CIVI
4677
DELISTED
Civitas Resources
CIVI
| $104K | ﹤0.01% |
4,599
-215
| -4% | -$4.95K |
2017 Q2
7 quarters
|
|
4678
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$668M
| $104K | ﹤0.01% |
2,330
-721
| -24% | -$31.5K |
2015 Q4
13 quarters
|
|
|
CBIO
4679
Crescent Biopharma
CBIO
$518M
| $104K | ﹤0.01% |
83
-233
| -74% | -$267K |
2018 Q2
3 quarters
|
|
4680
Northern Trust STOXX Global Broad Infrastructure ETF
NFRA
$2.98B
| $104K | ﹤0.01% |
2,100
| – | – |
2018 Q2
3 quarters
|
|
4681
PUT
Target
TGT
$69.5B
| $104K | ﹤0.01% |
+1,300
| New | +$95K |
2019 Q1
0 quarters
|
|
4682
Transcat
TRNS
$848M
| $104K | ﹤0.01% |
+4,533
| New | +$102K |
2019 Q1
0 quarters
|
|
|
EXFO
4683
DELISTED
EXFO INC.
EXFO
| $104K | ﹤0.01% |
28,353
| – | – |
2015 Q4
13 quarters
|
|
4684
VanEck Intermediate Muni ETF
ITM
$2.1B
| $103K | ﹤0.01% |
2,118
| – | – |
2016 Q2
11 quarters
|
|
4685
iShares Global Consumer Staples ETF
KXI
$1.11B
| $102K | ﹤0.01% |
+1,981
| New | +$96.9K |
2019 Q1
0 quarters
|
|
4686
MasterCraft Boat Holdings
MCFT
$480M
| $102K | ﹤0.01% |
4,499
-55,565
| -93% | -$1.23M |
2017 Q4
5 quarters
|
|
|
IMGN
4687
DELISTED
Immunogen Inc
IMGN
| $102K | ﹤0.01% |
37,795
-1,506
| -4% | -$6.52K |
2016 Q4
9 quarters
|
|
4688
Rocket Pharmaceuticals
RCKT
$287M
| $101K | ﹤0.01% |
5,764
-17,256
| -75% | -$272K |
2018 Q2
3 quarters
|
|
4689
Vanguard Global ex-US Real Estate ETF
VNQI
$3.24B
| $101K | ﹤0.01% |
1,700
-448
| -21% | -$25.4K |
2018 Q2
3 quarters
|
|
4690
Woori Financial
WF
$18.6B
| $101K | ﹤0.01% |
2,824
-7,867
| -74% | -$306K |
2015 Q4
13 quarters
|
|
|
AVYA
4691
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $101K | ﹤0.01% |
+6,000
| New | +$94K |
2019 Q1
0 quarters
|
|
4692
iShares Global 100 ETF
IOO
$9.29B
| $100K | ﹤0.01% |
2,100
-400
| -16% | -$18.2K |
2017 Q2
7 quarters
|
|
4693
CALL
Vipshop
VIPS
$6.04B
| $100K | ﹤0.01% |
12,400
-110,000
| -90% | -$779K |
2018 Q1
4 quarters
|
|
4694
WisdomTree Europe SmallCap Dividend Fund
DFE
$162M
| $99K | ﹤0.01% |
1,700
| – | – |
2014 Q2
19 quarters
|
|
|
CASA
4695
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $99K | ﹤0.01% |
11,842
+322
| +3% | +$3.57K |
2018 Q1
4 quarters
|
|
|
HCCI
4696
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $99K | ﹤0.01% |
3,614
-1,215
| -25% | -$30.9K |
2017 Q4
5 quarters
|
|
4697
Calix
CALX
$2.16B
| $98K | ﹤0.01% |
12,739
-1,207
| -9% | -$10.6K |
2017 Q4
5 quarters
|
|
4698
Global Industrial
GIC
$1.66B
| $98K | ﹤0.01% |
4,287
-3,253
| -43% | -$74.2K |
2016 Q4
9 quarters
|
|
4699
Gogo Inc
GOGO
$290M
| $98K | ﹤0.01% |
21,866
+212
| +1% | +$884 |
2016 Q3
10 quarters
|
|
|
MMAC
4700
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $98K | ﹤0.01% |
+3,225
| New | +$92.6K |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.